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ABSTRACT Yeast Saccharomyces cerevisiae contains two
genes, RAS] and RAS2, which show remarkable homology to
mammalian ras genes. To characterize these gene products, we
have expressed the RAS2 gene in yeast using an inducible
GALIO promoter. After labeling with [35S~methionine and im-
munoprecipitating with a monoclonal antibody Y13-259,
which reacts with p21 encoded by mammalian ras genes, a ma-
jor band having an apparent molecular weight of 41,000 is
detected. This band has also been identified in cell-free trans-
lation products of polyadenylylated RNA extracted from yeast
ceils grown in the presence of galactose. Crude extracts of cells
expressing the RAS2 gene exhibit guanine nucleotide binding
activity. This is detected by incubation with [3HJGDP followed
by immunoprecipitation with the antibody Y13-259. The bind-
ing of labeled GDP is inhibited by a 20-fold excess of GDP,
GTP, and, to a lesser extent, by UTP, a characteristic similar
to that possessed by the mammalian ras proteins. However,
the activity of the yeast protein differs from that of the mam-
malian proteins in its strong dependence on temperature. The
guanine nucleotide binding activity provides an assay to purify
the yeast protein.
Transfection of NIH 3T3 cells with DNAs from a variety of
human tumors has resulted in the detection of transforming
genes (1), most of which have been shown to be related to
the oncogenes carried by Harvey and Kirsten viruses (2-5).
These ras genes encode a Mr 21,000 protein (p21), which is
localized at the inner surface ofplasma membrane (6-8). The
p21 contains a lipid moiety detected by palmitic acid labeling
(9). An established biochemical activity of the p21 is its abili-
ty to bind guanine nucleotides (10, 11). In the case of viral
p21, it also exhibits autophosphorylation activity using GTP
as a phosphate donor (11).
Oncogenic variants of p21 are found as naturally occurring
mutants or as a result of in vitro mutagenesis (reviewed in
ref. 12). These studies indicate that there are five sites (the
12th, 13th, 59th, 61st, and 63rd amino acid residues) that
could be altered to convert a normal p21 to a form active in
the transformation of NIH 3T3 cells. At least for the change
at the 12th amino acid it is known that the change does not
significantly affect its guanine nucleotide binding activity
(13, 14). Recently, Gibbs et al. (15) reported that the auto-
phosphorylation of viral p21 is modulated by amino acid resi-
due 12. However, a detailed biochemical study is needed to
examine the difference between the wild-type protein and
the oncogenic variants. To aid such a study, expression of
the p21 in Escherichia coli has been accomplished recently
(16, 17).
The yeast Saccharomyces cerevisiae contains two genes,
RAS] and RAS2, which are highly homologous to mammali-
an ras genes (18, 19). Powers et al. (19) have shown that
yeast cells overproducing the RAS2 gene product contain
proteins having molecular weights of 42,000 and 30,000 that
can be immunoprecipitated by the monoclonal antibody
Y13-259. Papageorge et al. (20) detected three proteins, each
having a molecular weight of about 30,000, from wild-type
yeast cells that cross-react with the monoclonal antibody.
Neither the RAS] nor RAS2 gene itself is essential for the
growth of yeast, but yeast cells that have both RAS] and
RAS2 genes destroyed are incapable of vegetative growth
(21, 22). The amino acid residues responsible for the trans-
forming activity of the p21 are conserved in the yeast genes.
Conversion of glycine to valine at the 19th amino acid of the
yeast RAS2 affects the physiology of yeast, including sporu-
lation efficiency (22). This strongly suggests that the yeast
RAS products function in a manner similar to that of the
mammalian p21. Thus, yeast provides a convenient system
for the enzymological study of ras proteins. In addition,
powerful genetic approaches are available to confirm bio-
chemical findings.
In this paper, we report characterization of the yeast
RAS2 protein overproduced in yeast. The protein exhibits
guanine nucleotide binding activity similar to that possessed
by the mammalian p21. The activity provides a simple assay
for the purification of the yeast protein. This is just the first
step in ultimately understanding the biochemical activity of
the yeast RAS proteins and the difference between wild-type
protein and mutant proteins, which cause alterations in the
growth of yeast.
MATERIALS AND METHODS
Chemicals and DNAs. [3H]GDP (7.8 Ci/mmol; 1 Ci = 37
GBq) and [35S]methionine (1106.6 Ci/mmol) were obtained
from New England Nuclear. ATP, GTP, GDP, GMP, CTP,
and UTP were purchased from Sigma. Plasmid YEp51 was
obtained from J. Broach (23), and the HincIl fragment con-
taining the RAS2 gene has been described (19).
Cell Labeling and Immunoprecipitation. S. cerevisiae
KPPK-1 [derived from SP1 and SX 50-1C (22)] containing
the YEp51-RAS2 were first grown at 31°C in a synthetic me-
dium containing 2% (vol/vol) glycerol, 0.67% nitrogen base,
and appropriate amino acids. Cells were then grown to 2.4 x
107 cells per ml in a synthetic medium containing 5% galac-
tose or 2% glucose instead of glycerol. The cells were col-
lected and resuspended in an appropriate synthetic medium
lacking leucine and methionine. After growing at 31°C for 30
min, 250 ,Ci of [35S]methionine was added to the 10-ml cul-
ture. The labeled cells were collected by centrifugation,
washed once with phosphate buffered saline (P1/NaCI) and
kept frozen. After thawing, the cells were broken by mixing
on a Vortex with glass beads in P1/NaCl/1% Triton X-
100/0.5% deoxycholate/l mM phenylmethylsulfonyl fluo-
ride/aprotinin (0.1 mg/ml) (Sigma). The extract was clarified
and immunoprecipitated with a monoclonal antibody Y13-
259 (8) and analyzed by NaDodSO4/PAGE as described (5).
RNA Isolation and Cell-Free Translation. A 100-ml culture
of cells grown to a density of 6 x 107 cells per ml was har-
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vested, washed with cold water, and resuspended in 1 ml of
20 mM Tris HCl (pH 7.5)/0.3 M sucrose/10 mM EDTA/hep-
arin (0.5 mg/ml). An equal volume of cold glass beads was
added, and the mixture was mixed on a Vortex for 1 n'in.
Ten volumes of 50 mM Tris HCl (pH 7.5)/100 mM NaCl/5
mM EDTA/1% NaDodSO4/heparin (0.5 mg/ml) was added.
After mixing, the solution was extracted once with phenol,
twice with phenol/chloroform, and once with ether. Nucleic
acids were precipitated from the aqueous phase by adding
NaCl to 0.3 M and an equal volume of isopropanol. The pre-
cipitate was resuspended in 1 ml of 50 mM Tris-HCI (pH
7.5)/10 mM EDTA/500 mM NaCl/0.1% NaDodSO4, loaded
onto a 0.5 ml oligo(dT) cellulose column, washed with 2 ml
of 50 mM Tris HCI (pH 7.5)/10 mM EDTA/500 mM NaCI,
and eluted with 2 ml of H20. Cell-free translation of the poly-
adenylylated RNA using a reticulocyte lysate was carried
out according to Stillman et al. (24).
Preparation of Extracts. ICPPK-1 cells carrying YEp51-
RAS2 were grown at 31°C in synthetic medium containing
5% galactose to 3 x 1 cells per ml. The cells were collect-
ed, washed with P1/NaCl and frozen at -20°C. After thaw-
ing, the cells were resuspended in 2/3 vol of buffer A (10 mM
Tris HCI (pH 7.4)/50 mM NaCI/0.1 mM EDTA/0.1 mM di-
thiothreitol/0.5 mM phenylmethylsulfonyl fluoride), 1% Tri-
ton X-100, and 5 mM MgCl2. Glass beads (2/3 vol) were add-
ed and the cells were broken by mixing on a Vortex. The
extract was clarified by centrifugation at 100,000 x g for 60
min. The protein concentration of such an extract was -10
mg/ml. The extract was stable when kept at -70°C but lost
70% of the activity when kept on ice for a week.
Nucleotide Binding Assay. Each reaction mixture con-
tained buffer A, 5 mM MgCl2, 1% Triton X-100, 20 ,.M
[3H]GDP (specific activity, 7.8 Ci/mmol), and various
amounts of extracts in a volume of 50 Al. After incubation at
a temperature indicated in the figure legends, 3 A.l of mono-
clonal antibody Y13-259 was added and the mixture was ro-
tated for 2 hr in a cold room. The sample was diluted 1:5 with
buffer A and 5 mM MgCl2, 1% Triton X-100, and 10 ,ul of
rabbit anti-rat IgG (4 mg/ml from Cappel Laboratories,
Cochranville, PA) was added. After 1 hr on ice, 40 ,ul of pro-
tein A Sepharose (Pharmacia) was added, and the sample
was rotated in a cold room. The immune complexes were
precipitated by centrifugation and washed 4 times with 1 ml
each of buffer A, 5 mM MgCl2, 0.01% Triton X-100. The
precipitates were suspended in 60 ,ul of Laemmli solution
(25), transferred to new tubes, and boiled for 3 min. After
centrifugation, the supernatant was recovered and assayed
for radioactivity in a Beckman scintillation counter. Under
this condition, 5648 cpm represents 1 pmol of [3H]GDP.
RESULTS
Cloning ofRAS2 Gene Under a GALIO Promoter. Since the
RAS2 gene is not heavily transcribed in normal cells (19), we
decided to overproduce the gene product in yeast. A GALIO
expression system (23) was chosen for this purpose, because
a sharp induction of the expression is obtained. The expres-
sion is from a gene on a vector that replicates as an extra-
chromosomal plasmid. The strategy of cloning the RAS2
gene into this expression vector is shown in Fig. 1. In addi-
tion to a GALIO promoter, which is inducible by the addition
of galactose, the expression vector YEp51 contains a tran-
scription termination site from the 2-,m circle, located distal
to the promoter. Therefore, a 1161-base-pair HincII frag-
ment containing the RAS2 gene was inserted between the
promoter and the termination site, using Sal I and BEl I sites
of YEp51. The RAS2 HincII fragment contains 39 base pairs
upstream of the initiating ATG, in which there are no other
initiation or termination codons. The orientation of insertion
was verified by digesting the construct with Pst I. The clone
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FIG. 1. Cloning of the yeast RAS2 gene under control of GALJO
promoter. Yeast expression vector YEp51 contains the ColEl origin
of replication and the gene for ,-lactamase to facilitate its propaga-
tion in E. coli. The plasmid is grown in a dam- strain of E. coli. In
addition, it contains the LEU2 gene of yeast, the 2-,Atm circle origin
of replication, and the REP3 locus, as well as the GAL10 promoter
and transcription termination site (T). The YEp51 DNA was digest-
ed with Sal I and Bcl I, filled in with the Klenow fragment of E. coli
DNA polymerase I, and ligated to the HincII fragment containing
the yeast RAS2 gene. A Pst I site is present in the RAS2 gene 195
nucleotides from the ATG.
YEp51-RAS2 was then used to transform a leucine-requiring
strain of yeast.
Expression ofRAS2 Gene in Yeast. To examine the expres-
sion of the RAS2 gene, yeast cells carrying YEp51-RAS2
were grown in medium containing either galactose or glu-
cose. The cells were labeled with [35S]methionine, and the
labeled proteins were subjected to immunoprecipitation with
the monoclonal antibody Y13-259, which reacts with mam-
malian ras proteins. This antibody cross-reacts with yeast
proteips related to the mammalian ras proteins (19, 20). As
shown in Fig. 2A, immunoprecipitable bands shown by ar-
rows were detected when the cells were grown in the pres-
ence ofgalactose but not detected when the cells were grown
in the presence of glucose. A major band was observed at the
position corresponding to Mr -41,000. Minor bands, one at
Mr 38,000 and three others at Mr -30,000, were also ob-
served. Only a faint band was detected at the Mr 41,000 pro-
tein position when ceils containing the vector YEp51 were
used (unpublished data).
To investigate which band represents the primary transla-
tion product, we carried out the labeling for a brief period.
As can be seen in Fig. 2B, virtually identical labeling pat-
terns were obtained whether cells were labeled for 1, 2, 10,
or 60 min or labeled for 10 min and chased with a 7000-fold
excess of unlabeled methionine for 100 min. Therefore, no
apparent precursor-product relationship is found between
these bands. The chase experiment suggests that the ex-
pressed RAS2 protein is stable for at least 100 min.
We have also compared the labeled bands with cell-free
translation products. RNA was extracted from yeast cells
and polyadenylylated RNA was prepared by oligo(dT) cellu-
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FIG. 2. Identification of yeast RAS2 gene products. (A) Galactose-dependent expression of the RAS2 proteins. Yeast cells containing
YEp51-RAS2 were grown at 31'C to 2 x 107 cells per ml in galactose-containing medium (lanes 2 and 3) or in glucose-containing medium (lanes
4 and 5). The cells were labeled with [35S]methionine for 3 hr, disrupted by glass beads, and immunoprecipitated with the monoclonal antibody
Y13-259 (lanes 2 and 4). The same extracts were used to carry out mock immunoprecipitation without the Y13-259 (lanes 3 and 5). Lane 1 shows
total 5S-labeled proteins. Lane 6 shows size markers (Mr X 10-3): albumin, 69; ovalbumin, 46; carbonic anhydrase, 30; and cytochrome C,
12.3. (B) Labeling of RAS2 proteins with [35S]methionine. Yeast cells containing YEp51-RAS2 were grown in galactose-containing medium at
31'C to 2 x 107 cells per ml and labeled with [35S]methionine for 1 min (lane 1), 2 min (lane 2), and 10 min (lane 3). In another set of experiments,
the cells were also labeled for 10 min (lane 4) or 60 min (lane 6) with [35S]methionine or for 10 min with [35S]methionine followed by a chase for
100 min with 160 ,uM unlabeled methionine (lane 5). The cells were quickly chilled on ice and collected. After breaking the cells, immunoprecip-
itation was carried out with the Y13-259. (C) Cell-free translation of polyadenylylated RNA. Polyadenylylated RNA was isolated from yeast
cells carrying YEp51-RAS2 grown in galactose-containing medium. The RNA was translated by reticulocyte lysate and "S-labeled proteins
were immunoprecipitated with (lane 1) or without (lane 2) monoclonal antibody Y13-259. Lane 3 shows immunoprecipitates from [35S]methion-
ine-labeled cells grown in galactose-containing medium run on the same gel. Lane 4 shows size markers identical to those in lane 6 of A.
Numbers indicate Mr X 10
lose chromatography. RNA blot hybridization of the polyad-
enylylated RNA separated on formaldehyde gel with nick-
translated RAS2 probe indicated that the RAS2 transcript is
accumulated in the preparation extracted from cells grown in
the presence of galactose but not in the preparation from glu-
cose-grown cells (unpublished data). When the polyadenyl-
ylated RNA was translated by reticulocyte lysate and the
immunoprecipitation of products using the monoclonal Y13-
259 was performed, a single band migrating around Mr
41,000 was observed (Fig. 2C). Therefore, the major methio-
nine-labeled band having an apparent molecular weight of
41,000 appears to be the primary translation product. As de-
termined by immunoprecipitation, RAS protein represents
0.5% of radioactively labeled proteins during a 60-min pulse
(unpublished data). We do not know the degree of amplifica-
tion of RAS2 expression we have obtained. However, this
level of amplification does not seem to affect the growth of
yeast, because the doubling time and shape of the yeast ap-
peared normal.
Guanine Nucleotide Binding' Activity of the RAS2 Protein.
A high degree of amino acid homology between the yeast
RAS proteins and the mammalian ras proteins raises the pos-
sibility that the yeast protein contains guanine nucleotide
binding activity. To investigate this possibility, extracts
were incubated with [3H]GDP, immunoprecipitated with the
monoclonal antibody 259, and the radioactivity in the precip-
itates was determined. As can be seen in Fig. 3, extracts
prepared from cells grown in galactose-containing medium
exhibited strong GDP binding activity. On the other hand,
extracts prepared from cells grown in glucose-containing
medium did not show any significant activity. Adding glu-
cose extracts to galactose extracts did not affect the GDP
binding activity of the galactose extracts, indicating that
there are no inhibitory factors in the glucose extracts. The
GDP binding activity of the RAS2 protein is strongly depen-
dent on incubation temperature, as can be seen in Table 1.
When the incubation with GDP was carried out at 0°C, no
significant binding was detected even after 1 hr of incuba-
tion. This is in contrast to the activity of mammalian p21,
with which essentially the same level of binding is detected
at 0°C as at 37°C (10).
Characterization of the Guanine Nucleotide Binding Activi-
ty. To characterize further the guanine nucleotide binding
activity of the RAS2 protein, crude extracts prepared from
cells grown in the presence of galactose were cleared by high
speed centrifugation and then applied onto a column of phos-
phocellulose. As shown in Fig. 4, the activity bound to the
column and was eluted at the salt concentration of 0.17 M.
The overall recovery was -70%, and the chromatography
resulted in 20-fold purification over the high speed superna-
tant (S100). Examination of proteins in the peak fractions
suggested that the Mr 41,000 protein was enriched. Thus, the
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FIG. 3. Galactose-dependent expression of guanine nucleotide
binding activity. Appropriate amounts of crude extracts prepared
from cells grown in the presence of galactose (e) or glucose (o) were
incubated for 1 hr at 300C with [3H]GDP and immunoprecipitated
with the monoclonal antibody Y13-259.
guanine nucleotide binding activity provides an assay to pu-
rify the RAS2 protein.
Using the phosphocellulose purified protein, we have also
examined the ability of other nucleotides to compete with
GDP. As can be seen in Table 2, 20-fold excess of GTP or
GDP completely abolished the activity. GMP did not show
any competition. Thus, at least two phosphate groups are
needed for the binding. The binding appears to be specific
for guanine nucleotides, because ATP, CTP, and UTP com-
peted far less efficiently than GTP. In fact, virtually no com-
petition was seen with ATP. It is interesting to note that UTP
competed to some extent. Such an observation is also made
with the mammalian v-Ha-ras protein (10). Therefore, the
GTP binding property of the yeast RAS2 protein is strikingly
similar to that of the mammalian ras proteins.
DISCUSSION
Yeast RAS genes were originally identified by their se-
quence homology with mammalian ras genes. The observa-
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Table 1. Effect of incubation temperature on the guanine
nucleotide binding activity
Incubation [3H]GDP bound,
temperature, 0C pmol
0 0.058
30 0.815
37 1.378
45 1.035
Crude extracts (194 gg of total protein) prepared from cells grown
in the presence of galactose were incubated with [3H]GDP for 1 hr at
the indicated temperature.
tion that changing the 19th amino acid from glycine to valine
alters the physiology of yeast (22) points to a close similarity
in the way the yeast and mammalian proteins function. Our
finding that a product of one of the yeast RAS genes exhibits
guanine nucleotide binding activity indicates the similarity of
biochemical activity of the two proteins. This further sub-
stantiates the idea that yeast could serve as a model system
to understand the biochemical mechanisms of ras function.
Since the level of RAS2 protein in yeast is low (see Fig.
2A), we have overproduced the protein using an inducible
GAL10 promoter. We have identified a major band having an
apparent Mr of 41,000 as the primary translation product by
performing a brief labeling with [35S]methionine and by
translating polyadenylylated RNA by reticulocyte lysate.
The apparent molecular weight is slightly higher than that
predicted by its amino acid sequence. However, this could
be due to an anomalous electrophoretic mobility of the pro-
tein. We have also detected minor bands after labeling with
methionine: one around Mr 38,000 and three bands around
Mr 30,000. The latter could be identical to the three bands
detected by Papageorge et al. (20). These minor bands were
observed even after a 1-min pulse, and we have not been
able to establish any precursor-product relationship. We
have also examined the possibility of glycosylation by treat-
ing the immunoprecipitated proteins with trifluoromethane-
sulfonic acid. Again, we saw no change in the pattern of im-
munoprecipitated proteins (unpublished data). Thus, it is
more likely that the minor bands represent degradation prod-
ucts of the primary translation product. If so, it is interesting
to note that the degradation occurs in a very specific way.
The overproduction of the RAS2 protein enabled us to
demonstrate unambiguously that the yeast protein exhibits
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FIG. 4. Phosphocellulose column chromatography of the guanine nucleotide binding activity. Crude extracts (9.5 ml) were prepared from 5 g
of cells grown in galactose-containing medium. The extracts were centrifuged for 60 min at 40,000 rpm in a 50 Ti rotor. The recovery of the
activity in this step was almost 100%. This high speed supernatant (7 ml) was loaded onto a 10-ml column of phosphocellulose (P11), equilibrat-
ed with buffer A and 5 mM MgCl2. After washing with 10 ml of buffer A and 5 mM MgC12, elution was carried out by the linear gradient of buffer
A/5 mM MgCl2 and buffer A/5 mM MgCl2/0.5 M NaCI (50 ml each). Fraction volume was 2 ml. The microliters from each fraction was assayed
for guanine nucleotide binding activity by incubating for 1 hr at 37°C with [3H]GDP. *, [3H]GDP bound; - - - -, protein concentration; , salt
concentration.
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Table 2. Effects of addition of other nucleotides on binding
of [3H]GDP
Competitor (3H]GDP bound,
added pmol
None 0.68
GTP 0.01
GDP 0.03
GMP 0.64
ATP 0.57
CTP 0.49
UTP 0.31
Phosphocellulose fraction 13 (20 1.l) (Fig. 4) was incubated with
(3H]GDP for 1 hr at 370C. The potential competing nucleotide was
added prior to the [3H]GDP and was in 20-fold molar excess. Immu-
noprecipitation was carried out after the incubation.
guanine nucleotide binding activity. The binding activity is
specific to di- and triphosphate forms of guanine nucleotide,
and a weak competition of UTP with GDP is seen. This is in
remarkable agreement with the mammalian ras protein (10).
We have also observed that the guanine nucleotide binding
activity of the yeast RAS protein is strongly dependent on
incubation temperature. This is in contrast to the mammalian
proteifl, for which the activity is easily detected at 0C. We
do not know the reason for this temperature dependence. It
may be that the GTP binding site of the yeast protein is bur-
ied within the protein so that local unfolding is needed for the
GTP to bind.
The guanine nucleotide binding activity provides a simple
assay to purify the yeast RAS2 protein, which enables us to
characterize further its biochemical activity. An intriguing
question is whether there is any difference in guanine nucle-
otide binding activity between the wild-type protein and mu-
tant proteins that alter the physiology of yeast. To attack this
problem, we have overproduced mutant forms of the RAS2
protein and are studying their comparative biochemical
properties. A variety of proteins are known that exhibit high
affinity for guanine nucleotides. The "G" proteins of adenyl-
ate cyclase bind GTP, which results in the dissociation of
interacting proteins. This enables the interacting proteins to
stimulate the catalytic subunit of adenylate cyclase (26). A
similar mechanism is proposed for the G protein of cyclic
GMP-dependent phosphodiesterase (27). Elegant studies
have been carried out with other GTP binding proteins, EF-
Tu and EF-G. The binding of GTP alters the conformation of
these proteins, thus affecting their interaction with ribo-
somes (reviewed in ref. 28). Whether the yeast RAS2 protein
functions in a similar manner and whether the GTP binding
affects its protein conformation will become clearer after
further purification and characterization of the protein.
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